1-866-647-3279

Pharmaceutical Research & Consulting

Helping clients navigate FDA and Health Canada regulations since 2002

0
+
Years in Service
0
+
Experts
0
+
Projects Completed

The dicentra advantage

Our interdisciplinary pharmaceutical team has combined experience in drug applications and submissions, quality management, regulatory compliance, and clinical trials

Our Pharmaceutical Services

PillBottle_Block_V1D1_ML

Drug Applications & Submissions

  • New Drug Applications (NDA) including 505(b)(1) & 505(b)(2) applications
  • Abbreviated new drug applications (ANDA) and supplemental new drug applications (SNDA)
  • Investigational New Drug (IND) applications
  • Drug Establishment Registration and Labellor code request
  • Over-the-counter (OTC) Drug Product Registration
  • New Drug Submission (NDS)
  • Abbreviated New Drug Submission (ANDS) and Supplement to a New Drug Submission (SNDS)
  • Drug Identification Number (DIN) application
  • Drug Establishment Licence (DEL)
  • Non-Prescription (OTC) drug registration
  • Non-prescription drug monograph attestation
  • Prescription to OTC Switch (Rx to OTC)
PillsInspection_Block_V1D1_ML

Quality Systems Compliance Services

  • Good Manufacturing Practice (GMP) Services
  • Good Laboratory Practice (GLP) Services
  • Good Clinical Practice (GCP) Services
  • Strategy and risk analysis
  • QMS design and development
  • QMS audit and assessment against FDA 21 CFR Part 201
  • QMS audit and assessment against Part C, Division 2 of Canada’s Food and Drug Regulations
  • QMS verification and improvement
  • SOP & PnP preparation and review
  • Third-party CGMP Audit
  • Quality system training
Binders_V3D1_ML

Regulatory Compliance

  • Drug classification (monograph vs. new drug; prescription vs. non-prescription)
  • Determine whether your product meets Generally Recognized as Safe and Effective (GRASE) conditions
  • Changes Being Effected (CBE) filing, Changes Being Effected in 30 days (CBE 30) filing
  • Annual Report preparation
  • Prior Approval Supplement (PAS)
  • Notifiable Change (NC) & Notice of Compliance (NOC)
  • Major change, moderate change, minor change reporting
  • Annual Drug Notification Form (ADNF) preparation
  • Drug Labelling
  • Adverse event reporting/Adverse reaction reporting
WaitingArea_V1D1_ML

Clinical Trials

  • Pre-clinical trials
  • Pharmacokinetics/Pharmacodynamics (Pk/Pd)
  • Bioequivalence studies
  • Recruitment
  • Phase I/IIa Clinical Trials
  • Phase II/III Clinical Trials
  • Phase IV/Post marketing surveillance
  • Pharmacovigilance
  • Biostatistics

Let's Work Together

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions

      *Please note: dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in Canada, to the exclusion of all other countries.